Logo

Roswell Biotechnologies: Mike Aicher

Oct 08, 2021

Roswell Biotechnologies, a company developing single-molecular analysis platforms based on semiconductor chip technology, has appointed Mike Aicher as chairman of its board of directors. Aicher was president and founder of Alveo Technologies, an infectious disease testing startup. He cofounded and served as CEO of the National Genetics Institute (which became part of LabCorp in 2000) for more than two decades. He is also an executive director at Genetic Signatures, chairman of CytoBay, and a member of Techcyte's board of directors. Aicher previously served on the board of directors for Fabric Genomics, and was a board member of Ariosa until its acquisition by Roche.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.